Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/6/2024 | Outperform → Mkt Perform | William Blair | |
12/15/2023 | $8.00 | Equal Weight → Underweight | Wells Fargo |
10/16/2023 | $10.00 → $8.50 | Hold → Buy | Jefferies |
9/8/2023 | $8.00 → $7.00 | Equal Weight → Underweight | Barclays |
8/25/2023 | $9.00 → $8.00 | Outperform → Sector Perform | RBC Capital Mkts |
8/7/2023 | $10.00 → $6.00 | Neutral → Underperform | BofA Securities |
8/4/2023 | $15.00 → $8.00 | Overweight → Equal Weight | Wells Fargo |
6/13/2023 | $11.00 | Outperform | Oppenheimer |
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
SC 13G/A - CLARIVATE PLC (0001764046) (Subject)
SC 13G - CLARIVATE PLC (0001764046) (Subject)
SC 13D/A - CLARIVATE PLC (0001764046) (Subject)
William Blair downgraded Clarivate from Outperform to Mkt Perform
Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00
Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously
8-K - CLARIVATE PLC (0001764046) (Filer)
8-K - CLARIVATE PLC (0001764046) (Filer)
SCHEDULE 13G/A - CLARIVATE PLC (0001764046) (Subject)
Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions LONDON, June 3, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN), a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members.
LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, announced today that it has successfully completed an incremental upsize of its term loan B credit facility. Pursuant to an amendment to the Company's existing credit agreement dated as of October 31, 2019, the Company incurred a new $500 million tranche of incremental term loans maturing in 2031, with an interest rate margin of 325 basis points per annum in the case of loans bearing interest by reference to term SOFR. The ne
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality researc
Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,
Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader
Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.
— Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202
LONDON, April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, April 29, 2025 to review the results. The webcast is open to all interested
— Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON, Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024.
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)